First Citizens Bank & Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

First Citizens Bank & Trust’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,233	Closed	-$213K	–	446
2018 Q3	$213K	Sell	4,233 -18	-0.4%	-$889	0.02%	398
2018 Q2	$254K	Sell	4,251 -652	-13%	-$33.8K	0.03%	375
2018 Q1	$225K	Buy	+4,903	New	+$205K	0.03%	379
2017 Q3	–	Sell	-5,397	Closed	-$233K	–	452
2017 Q2	$233K	Sell	5,397 -1,234	-19%	-$43.9K	0.03%	391
2017 Q1	$208K	Buy	+6,631	New	+$178K	0.03%	447
2016 Q4	–	Sell	-9,745	Closed	-$241K	–	474
2016 Q3	$241K	Buy	+9,745	New	+$221K	0.02%	436

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

First Citizens Bank & Trust's SUPN Position: Q4 2018 in Review

First Citizens Bank & Trust sold out of Supernus Pharmaceuticals (SUPN) in Q4 2018, closing a stake of 4,233 shares — an estimated $213K sold.

First Citizens Bank & Trust first reported a position in SUPN in Q3 2016 and held it in 6 quarters. The position peaked at $254K in Q2 2018. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

First Citizens Bank & Trust reported no remaining Supernus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
First Citizens Bank & Trust sold 4,233 Supernus Pharmaceuticals shares in Q4 2018, an estimated $213K.
First Citizens Bank & Trust first reported a position in Supernus Pharmaceuticals in Q3 2016 and held it in 6 quarters.
First Citizens Bank & Trust's Supernus Pharmaceuticals position peaked at $254K in Q2 2018.
274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on First Citizens Bank & Trust's 13F filing for Q4 2018, filed 15 Jan 2019.